Prediction of response to vemurafenib in BRAF V600E mutant cancers based on a network approach

被引：0
|
作者：
Falcone, R. [1 ]
Paci, P. [2 ]
Verrienti, A. [1 ]
Fiscon, G. [2 ]
Sponziello, M. [1 ]
Conte, F. [2 ]
Pecce, V. [1 ]
Rosignolo, F. [1 ]
Grani, G. [1 ]
Lamartina, L. [1 ]
Ramundo, V. [1 ]
Durante, C. [1 ]
Farina, L. [3 ]
Filetti, S. [1 ]
机构：
[1] Sapienza Univ Rome, Policlin Umberto 1, Dipartimento Med Interna & Specialita Med, Rome, Italy
[2] CNR, Inst Syst Anal & Comp Sci Antonio Ruberti, Rome, Italy
[3] Sapienza Univ Rome, Dept Stat Sci, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1887P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Response to combined BRAF/MEK inhibition in adult BRAF V600E mutant spinal pilocytic astrocytoma
    Balasubramanian, Adithya
    Gunjur, Ashray
    Gan, Hui Kong
    Perchyonok, Yuliya
    Cher, Lawrence Myron
    JOURNAL OF CLINICAL NEUROSCIENCE, 2020, 79 : 269 - 271
  • [32] Rapid response of biallelic BRAF V600E mutated hairy cell leukaemia to low dose vemurafenib
    Follows, George A.
    Sims, Hannah
    Bloxham, David M.
    Zenz, Thorsten
    Hopper, Melanie A.
    Liu, Hongxiang
    Bench, Anthony
    Wright, Penny
    van't Veer, Mars B.
    Scott, Mike A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 (01) : 150 - 153
  • [33] Comment on: Response to the BRAF/MEK inhibitors dabrafenib/trametinib in an adolescent with a BRAF V600E mutated anaplastic ganglioglioma intolerant to vemurafenib
    Bourque, Melissa S.
    Salek, Marta
    Sabin, Noah D.
    Canale, Meredith
    Upadhyaya, Santhosh A.
    PEDIATRIC BLOOD & CANCER, 2021, 68 (04)
  • [34] Evolving Acquired Vemurafenib Resistance in a BRAF V600E Mutant Melanoma PDTX Model to Reveal New Potential Targets
    Tovari, Jozsef
    Vari-Mezo, Diana
    Surguta, Sara Eszter
    Ladanyi, Andrea
    Kigyos, Attila
    Cserepes, Mihaly
    CELLS, 2023, 12 (14)
  • [35] A patient with malignant pleural mesothelioma carrying BRAF V600E mutation responding to vemurafenib
    Chen, Yao
    Chen, Baisong
    Zhu, Xiaolian
    Zhong, Jianping
    LUNG CANCER, 2018, 116 : 96 - 98
  • [36] Genomic complexity and BRAF/MEK-dependence in V600E BRAF mutant melanoma
    Xing, Feng
    Persaud, Yogindra
    Pratilas, Christine
    Janakiraman, Manickam
    She, Qing-Bai
    Liu, Cailian
    Dolgalev, Igor
    Heguy, Adriana
    Wolchok, Jedd
    Cobrinik, David
    Houghton, Alan
    Taylor, Barry
    Rosen, Neal
    Solit, David
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [37] THE CASE OF ACQUIRED VEMURAFENIB RESISTANCE IN BRAF V600E POSITIVE MULTISYSTEM PEDIATRIC LCH
    Lyudovskikh, Evelina
    Evseev, Dmitry
    Osipova, Daria
    Raykina, Elena
    Kalinina, Irina
    Baidildina, Dina
    Maschan, Alexey
    Maschan, Michael
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S31 - S31
  • [38] Thermodynamic and allosteric basis of paradoxical activation in V600E BRAF cancers
    Rasmussen, Damien
    Semonis, Manny
    Levinson, Nicholas
    BIOPHYSICAL JOURNAL, 2022, 121 (03) : 144 - 145
  • [39] Genetic predictors of MEK dependence in V600E BRAF mutant melanoma
    Xing, Feng
    Pratilas, Christine
    Persaud, Yogindra
    Janakiraman, Manickam
    Houghton, Alan
    Rosen, Neal
    Solit, David
    CANCER RESEARCH, 2009, 69
  • [40] Safety and efficacy of vemurafenib in BRAF V600E mutation-positive metastatic melanomas
    Andrea P Sponghini
    David Rondonotti
    Marco Giavarra
    Roberto Giorgione
    Francesca Platini
    Journal of Translational Medicine, 13 (Suppl 1)
12345